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Background and Objectives: Pluripotent embryonic stem (ES) cells represent a perfect model system for the inves-
tigation of early developmental processes. Besides their differentiation into derivatives of the three primary germ layers, 
they can also be differentiated into derivatives of the ‘fourth’ germ layer, the neural crest (NC). Due to its multipotency, 
extensive migration and outstanding capacity to generate a remarkable number of different cell types, the NC plays 
a key role in early developmental processes. Cardiac neural crest (CNC) cells are a subpopulation of the NC, which 
are of crucial importance for precise cardiovascular and pharyngeal glands’ development. CNC-associated malformations 
are rare, but always severe and life-threatening. Appropriate cell models could help to unravel underlying pathomechan-
isms and to develop new therapeutic options for relevant heart malformations. 
Methods: Murine ES cells were differentiated according to a mesodermal-lineage promoting protocol. Expression pro-
files of ES cell-derived progeny at various differentiation stages were investigated on transcript and protein level.
Results: Comparative expression profiling of murine ES cell multilineage progeny versus undifferentiated ES cells con-
firmed differentiation into known cell derivatives of the three primary germ layers and provided evidence that ES 
cells have the capacity to differentiate into NC/CNC-like cells. Applying the NC/CNC cell-specific marker, 4E9R, 
an unambiguous identification of ES cell-derived NC/CNC-like cells was achieved. 
Conclusions: Our findings will facilitate the establishment of an ES cell-derived CNC cell model for the investigation 
of molecular pathways during cardiac development in health and disease.
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Introduction 
  Pluripotent embryonic stem (ES) cells were first iso-
lated in 1981 from mouse blastocyst-staged embryos (1, 2). 
They have a nearly unlimited capacity of self-renewal and 
the potential to differentiate into cell derivatives of the ec-
todermal, endodermal and mesodermal lineage, in vivo 
and in vitro (3). ES cell culture models offer countless pos-
sibilities for the elucidation of gene regulation and func-
tion during early developmental processes, without harm-
ing animals (4). In particular, for the examination of early 
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embryonic cardiac development, ES cells represent a per-
fect model system as they recapitulate the programmed 
expression of cardiac genes, proteins, receptors and ion 
channels as reported for mouse embryos (5). 
  In one of our previous studies, murine ES cells have 
been differentiated until the intermediate stage 5＋9d ac-
cording to a mesodermal-lineage promoting protocol (6). 
Affymetrix gene chip analysis, comparing undifferentiated 
vs differentiated ES cells at the multilineage progeny stage 
5＋9d, revealed the up-regulation of transcripts known to 
be expressed in neural crest (NC) and cardiac neural crest 
(CNC) cells (Rolletschek et al., unpublished data; (6)) 
(Supplementary Table S1). NC cells are a transient, ex-
tensively migratory and multipotent cell lineage that aris-
es from the dorsal neural tube during early embryonic 
development. They are indispensable for proper early de-
velopment as they give rise to a prodigious number of dif-
ferentiated cell types (7, 8). Depending on their destina-
tion, they are classified into cranial, trunk, vagal and sa-
cral NC cells. The caudal subpopulation of cranial NC 
cells, originating from the dorsal neural tube between the 
midotic placode and the third somite, is termed the CNC 
(9, 10). CNC cells give rise to ectomesenchymal, neuronal 
and smooth muscle cells and play a crucial role in car-
diovascular and pharyngeal glands development. They mi-
grate to the developing cardiac outflow tract (OFT) and 
the proximal great vessels via the third, fourth and sixth 
pharyngeal arches (11). Ablation of premigratory CNC 
cells in chicken embryos and quail/chicken chimeras lead 
to conotruncal anomalies, including impaired OFT septa-
tion (persistent truncus arteriosus), abnormal patterning 
of the aortic arch arteries and great arteries, hypoplasia 
or absence of pharyngeal pouch derivatives, abnormal 
heart looping and ventricular septal defects (9, 12-14). In 
addition to structural defects, myocardial dysfunctions in-
cluding reduced ejection fraction, decreased L-type Ca2＋ 
currents and contractility as well as abnormal excitation- 
contraction coupling have been observed (9, 12-15). The 
homozygous splotch mouse mutant (Sp2H/Sp2H) represents 
the first mammalian model for CNC ablation phenotypes 
(16). Sp2H/Sp2H mice carry a mutation in the Pax3 gene, 
which is important for induction, maintenance, migration 
and differentiation of NC cells during embryonic develop-
ment. The majority of homozygous splotch embryos devel-
op persistent truncus arteriosus and die in utero at day 
14.5 post coitum due to impaired excitation-contraction 
coupling, causative for depressed myocardial function and 
death from cardiac failure (17-19). In humans, the CNC 
plays a crucial role in the pathogenesis of various syn-
dromes such as DiGeorge Syndrome, CHARGE Syndrome 
and Alagille Syndrome (reviewed in (20)). ES cell-derived 
cell models would be perfectly suited to explore under-
lying pathomechanisms in detail upon which improved 
therapeutic options might be established.
  Comparative expression analyses on mRNA and protein 
level verified the expression of up-regulated NC/CNC-as-
sociated markers, previously identified by Affymetrix gene 
chip analysis and furthermore underlined the potential of 
ES cells to be differentiated into NC/CNC-like cells. How-
ever, as examined NC/CNC-associated markers are not ex-
clusively expressed in those lineages (21), we additionally 
applied a designated NC/CNC cell-specific antibody, ter-
med 4E9R, to identify ES cell-derived NC/CNC-like cells 
unambiguously (22, 23). 
Materials and Methods
Cell culture and differentiation
  Murine ES cells of line R1 (24) were cultured in ES cell 
proliferation medium (Dulbecco’s modified eagle medium 
(DMEM), 15% fetal calf serum (FCS), 0.1 mM non-essen-
tial amino acids (NEAA), 0.5 mg/ml penicillin/strep-
tomycin/L-glutamine (all ThermoFisher Scientific, Wal-
tham, Massachusetts, USA), 0.1 mM β-mercaptoethanol 
and 1.5x leukemia inhibitory factor (LIF, both from 
Sigma-Aldrich, St. Louis, Missouri, USA)) on Mitomycin C 
(Sigma-Aldrich)-treated and mitotically inactivated mou-
se embryonic fibroblasts (MEFs) on 0.1% gelatin (Sigma- 
Aldrich)-coated 60 mm tissue culture petri dishes (25). 
Prior to differentiation, ES cells were cultured on 0.1% 
gelatin-coated petri dishes only for three passages to de-
crease the number of MEFs. Subsequently, ES cells were 
differentiated according to a mesodermal-lineage promot-
ing hanging drop protocol (600 cells/drop) (25). In brief, 
a cell suspension was prepared containing 600 cells in 20 μl 
ES cell differentiation medium (Iscove’s modified Dulbec-
co’s medium (IMDM), 20% FCS, 0.1 mM NEAA, 0.5 
mg/ml penicillin/streptomycin/L-glutamine (all Thermo-
Fisher Scientific) and 450 μM monothioglycerol (MTG, 
Sigma-Aldrich)). For embryoid body (EB) formation, cell 
suspension drops (600 cells/20 μl drop) were placed on 
the lid of a bacteriological 100 mm petri dish containing 
10 ml 1× PBS in the lower compartment (ThermoFisher 
Scientific). After two days in hanging drop culture, spher-
ical cell aggregates (EBs) were carefully rinsed from the 
lid and transferred in 60 mm bacteriological petri dishes 
using ES cell differentiation medium. EB expansion was 
performed for three further days in suspension culture. 
On day five of differentiation, EBs were plated on 0.1% 
gelatin-coated tissue culture plates for further differ-
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entiation and expansion into multilineage progenitor cells 
(25). Cells were cultivated at 37℃ in 5% CO2 and 95% 
humidity. ES cell-derived progeny were harvested at sev-
eral differentiation stages and lysed in respective buffers 
for further analyses as indicated below.
Morphological analysis
  For morphological characterization of ES cell-derived 
multilineage progenitor cells, five days old (5d) EBs were 
plated separately in 0.1% gelatin-coated 24-well plates 
(one EB/well). The appearance of beating cardiomyocytes, 
skeletal muscle or neuronal cells per EB was assessed, ev-
ery second or third day, by bright field microscopy using 
the inverted routine microscope CKX41 from Olympus 
(Olympus, Shinjuku, Tokio, Japan). The presence of the 
respective cell type per EB was counted (25, 26). 
RNA extraction and cDNA synthesis
  Total RNA was extracted from undifferentiated ES cells 
and their progeny at different stages using peqGOLD Tri-
Fast (VWR International, Radnor, Pennsylvania, USA) ac-
cording to the manufacturer’s instructions. Up to 1 μg 
total RNA was reverse transcribed using oligo(dT)18 pri-
mer and M-MLV reverse transcriptase (both Thermo-
Fisher Scientific).
Reverse transcription PCR analysis
  Reverse Transcription PCR (RT-PCR) analyses were 
carried out using the peqGOLD Taq-DNA-polymerase ‘all 
inclusive’ kit (VWR International). The amount of ampli-
fied PCR product was quantified in relation to the ex-
pression of the reference gene, Gapdh (Glyceraldehyde 
3-phosphate dehydrogenase), using the quantification soft-
ware tool TINA2.08e (Raytest, Isotopenmessgeräte GmbH, 
Straubenhardt, Germany) as previously described (27, 28). 
Expression analyses were performed from undifferentiated 
ES cells and ES cell-derived progeny at several differ-
entiation stages (formation of EBs in hanging drops: 2d; 
suspension culture and start of differentiation: 5d; days of 
differentiation: 5＋2d, ＋4d, ＋7d, ＋9d, ＋11d, ＋14d, ＋18d, 
＋25d, ＋30d, ＋35d) using ten independent biological 
replicates. Oligonucleotide sequences and experimental 
details are given in Supplementary Table S2.
Tissue preparation
  Female and male wildtype NMRI mice were kept ac-
cording to the German animal protection ordinance (Tier-
schutz-Versuchstierverordnung - TierSchVersV). 
  Tissues were prepared at several stages post fertili-
zation. Whole-mount embryos were prepared at embryonic 
stage (E) 9.5 and heart tissue was isolated at E10.5∼
E17.5, postnatal day (P) 8, P15 and from the adult. 
Primary mouse CNC cells were isolated at E10.5 and used 
for Western blot and immunoprecipitation (IP) analyses. 
Therefore, the tissue between the midotic placode and the 
third somite, harboring primary CNC cells, was resected 
from mouse embryos (E10.5) using fine preparation 
cutlery. Tissue specimens in general, were then either 
lysed in a commercially available cell disruption buffer 
(PARIS Protein & RNA Isolation Kit, ThermoFisher 
Scientific) or in NP-40 buffer (50 mM Tris pH 8.0, 5 mM 
EDTA, 150 mM NaCl, 1% NP-40) including protease in-
hibitor cocktail (all from Sigma-Aldrich) for downstream 
protein analyses.
Isolation of beating cardiac clusters
  Beating ES cell-derived cardiac cell clusters at differ-
entiation stages 5＋4d and 5＋7d were isolated according 
to (29). In brief, beating cell clusters were mechanically 
separated and enzymatically dissociated with collagenase 
NB8 solution (0.5 mg/ml collagenase NB8 (Serva Electro-
phoresis GmbH, Heidelberg, Germany), 3.51 g NaCl, 200 
mg KCl, 1.8 g Glucose (all from Merck Chemicals GmbH; 
Darmstadt, Germany), 615 mg MgSO4, 275 mg Na-Pyruvat, 
1.25 g Taurine, 1.19 g Hepes (all from Sigma-Aldrich) ad 
500 ml bidest. H2O, pH 6.9) for 20 min. at 37℃ in a 15 
ml centrifuge tube. After centrifugation, the cell pellet was 
resuspended in KB medium (634 mg KCl, 369 mg Glu-
cose, 522 mg K2HPO4 (all from Merck Chemicals GmbH), 
123 mg MgSO4, 38 mg EDTA, 55 mg Na-Pyruvat, 75 mg 
Kreatin, 250 mg Taurin (all from Sigma-Aldrich), ad 100 
ml bidest. H2O, pH 7.2) supplemented with 2 mM ATP 
(Carl Roth GmbH & Ko KG, Karlsruhe, Germany). 
Afterwards, resuspended cells were incubated for 1h at 
37℃. Thereafter, cells in KB medium were mixed with 
ES cell differentiation medium (1：1) and transferred on-
to 0.1% gelatin-coated cover slips in a 24-well plate. After 
6∼8 hours at 37℃, a complete medium change with ES 
cell differentiation medium was performed and cells were 
further cultivated. 24 hours after isolation, cells were fixed 
(5＋4＋1d, 5＋7＋1d) and used for immunofluorescence 
analyses.
Immunofluorescence analyses
  For immunofluorescence (IF) analyses, differentiated 
ES cell specimens and isolated beating cardiac clusters 
(29) were fixed in 4% paraformaldehyde (PFA, Sigma- 
Aldrich)/1× PBS (ThermoFisher Scientific) for 20 min at 
room temperature (RT). Subsequently, specimens were 
permeabilized using 0.1% TritonX100 (Sigma-Aldrich)/1× 
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PBS (except for ET-AR), blocked for 1 h at RT in 1% BSA 
(Serva Electrophoresis GmbH)/1× PBS and incubated 
with the respective primary antibodies for 1 h at RT. 
Primary antibodies are given in Supplementary Table S3. 
After washing with 1× PBS, cells were incubated at RT 
for 1 h with the following secondary antibodies: anti-rab-
bit, anti-goat and anti-mouse Cy3 (1：700; Dianova, 
Hamburg, Germany) or anti-mouse- and anti-rabbit Alexa 
Fluor 488 (1：100; Molecular Probes, Eugene, Oregon, 
USA). Nuclei were counterstained with DAPI (4’,6-dia-
midino-2-phenylindole, Sigma-Aldrich) and cover slipped 
in Vectashield mounting medium (Biozol, Eching, 
Germany) for long-term storage.
  For IF analyses using the 4E9R antibody (gift from 
Prof. Kazuo Ito, Osaka University, Japan) (22), following 
modifications were applied: differentiated ES cell speci-
mens were fixed with 0.1% formaldehyde/MeOH (both 
Sigma-Aldrich) and then rehydrated on ice. After blocking 
with 1% BSA/1× PBS, cells were incubated with primary 
antibodies overnight at 4℃. 
  For visualization the Axiovert 200M fluorescence micro-
scope from Zeiss (Carl Zeiss AG, Oberkochen, Germany) 
was used. 
Western blot analysis
  Primary CNC cells (E10.5), heart tissues (E10.5∼E17.5, 
P8, P15, adult) as well as ES cell-derived specimens (5d-5
＋25d) were homogenized and lysed in cell disruption buf-
fer (PARIS Protein & RNA Isolation Kit, ThermoFisher 
Scientific). Protein samples (60 μg) were separated by 
SDS-PAGE and blotted onto a PVDF membrane. 
Membranes were labeled either with Gapdh or 4E9R and 
myosin light polypeptide 6 (gene: Myl6) antibodies (Sup-
plementary Table S3). In the following, we will refer to 
myosin light polypeptide 6 as Mlc-3, using an official al-
ternative protein name (www.uniprot.org). Labeled pro-
teins were visualized using the ECL Plus chemilumine-
scent substrate (Sigma-Aldrich).
Immunoprecipitation
  An immunoprecipitation (IP) was performed with L- 
agarose (Sigma-Aldrich) according to the manufacturer’s 
instructions. Briefly, 100 μg protein lysate from E9.5 
whole-mount embryos, isolated E10.5 CNC cells, embry-
onic heart tissue (E10.5, E11.5, and E13.5), adult heart tis-
sue or ES cell specimens from 5＋7d and 5＋18d were 
lysed in NP-40 buffer. Protein lysates were incubated over-
night with 4E9R antibody at 4℃. L-agarose was added 
and samples were incubated for further 60 min at 4℃. 
Samples were washed and resuspended in 2× Laemmli 
buffer (1 M Tris pH 6.8, 10% β-mercaptoethanol, brom-
phenol blue (all from Sigma Aldrich), 20% SDS (Carl 
Roth, Karlsruhe, Germany), separated by SDS-PAGE and 
stained with Coomassie Blue (Sigma-Aldrich). Selected 
bands were cut out for nano-scale liquid chromatography 
electrospray ionization tandem mass spectrometry (nLC- 
ESI-MSMS) analysis (Proteome Factory, Berlin).
nLC-ESI-MSMS analysis
  Protein identification was performed by the Proteome 
Factory AG (Berlin, Germany). Protein spots were in-gel 
digested using sequencing-grade porcine trypsin (Promega 
Corporation, Madison, Wisconsin, USA) and analyzed by 
nLC-ESI-MSMS. The LC-MS/MS system consisted of an 
Agilent 1100 nanoHPLC system (Agilent Technologies 
Deutschland GmbH, Waldbronn, Germany), PicoTip elec-
trospray emitter (New Objective, Woburn, Massachusetts, 
USA) and a QStar XL mass spectrometer (Applied Biosys-
tems, Foster City, California, USA). Peptides were trap-
ped and desalted on the enrichment column (Zorbax 
300SB-C18, 0.3×5 mm, Agilent Technologies Deutschland 
GmbH) for five min (solvent: 2.5% acetonitrile/0.5% for-
mic acid), then separated on a Zorbax 300SB-C18, 75 μm 
×150 mm column (Agilent Technologies Deutschland 
GmbH) using a linear gradient from 10% A to 32% B 
(solvent A: 0.1% formic acid in water, solvent B: 0.1% for-
mic acid in acetonitrile, both Sigma-Aldrich). The three 
most abundant ions were data-dependently subjected to 
MS/MS according to the expected charge state distri-
bution of peptide ions. Proteins were identified by sear-
ching the NCBInr protein database using an MS/MS ion 
search of the Mascot search engine (Matrix Science Ltd., 
London, UK). The final report contained a list of proteins 
with a significant Mascot ion score, which is based on the 
calculated probability (P) that the monitored match be-
tween the experimental data and the database sequence is 
a random event. Hence, the ion score represents the neg-
ative logarithm of the probability (−10Log[P]) that a re-
sult could be false-positive. For reliable protein identi-
fication, the Mascot ion score should be around 100 (www. 
matrixscience.com).
Results
Murine ES cells can be differentiated into multilineage 
progeny 
  In order to elucidate the differentiation potential of ES 
cells under mesodermal lineage-promoting conditions, 
morphological assessment was performed by calculating 
the percentage of differentiating EBs showing the best dis-
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tinguishable cell types such as cardiomyocytes, skeletal 
muscle or neuronal cells (Supplementary Fig. S1). First 
beating cardiomyocytes appeared at the very early differ-
entiation stage 5＋4d. The beating was consistently detect-
able at all investigated stages, with peak occurrence be-
tween 5＋9d and 5＋11d. However, due to the increasing 
cell number over time and the associated space limi-
tations, the characteristic beating of cardiac clusters be-
came difficult to detect. Thus, the apparent reduction of 
cardiomyocytes in later stages may not reflect the real 
number of this cell type (Supplementary Fig. S1, in red). 
Skeletal muscle cells were first observed at stage 5＋9d 
and increased constantly until last assessed differentiation 
stage, 5＋18d (Supplementary Fig. S1, in yellow). First 
neuronal cells were also visible at the early differentiation 
stage 5＋4d, but most were detected between 5＋11d and 
5＋14d (Supplementary Fig. S1, in blue). Endodermal 
cells are morphologically difficult to specify, so we limited 
our analyses to ectodermal and mesodermal cell deriva-
tives.
  In summary, the morphological determination of EBs 
revealed mesodermal lineage-derived ES cell progeny as 
well as ectodermal derivatives such as neuronal cells.
Multilineage ES cell progeny express selected 
CNC-associated markers 
  To investigate the occurrence of ES cell-derived CNC- 
like cells, expression analyses using selected CNC-asso-
ciated markers (6, 30) were performed (Supplementary 
Table S4). Selected genes have known roles in the specifi-
cation (Pax3; Fig. 1A), epithelial-to-mesenchymal tran-
sition (Snai1, Snai2; Fig. 1B), migration (Gja1; Fig. 1C), 
arterial tree remodeling (Pitx2, Ednra, Mef2c, Hand1, 
Hand2; Fig. 1D) and myocardial development (Lbx1; Fig. 
1E) (30). Comparative expression analyses revealed an 
up-regulation of all investigated marker genes in differ-
entiated ES cell specimens compared to undifferentiated 
ES cell controls (Fig. 1A∼E). Snai1, Snai2 (both Fig. 1B), 
Gja1 (Fig. 1C), Pitx2 and Ednra (both Fig. 1D) were al-
most constantly expressed in all investigated differenti-
ation stages. Expression levels of Pax3 (Fig. 1A), Mef2c, 
Hand1, Hand2 (all Fig. 1D) and Lbx1 (Fig. 1E) increased 
over time until the intermediate differentiation stages 5＋
7d to 5＋11d. In later stages the expression of those genes 
decreased, except for Hand2 (Fig. 1D), which showed a 
slight up-regulation at stage 5＋35d. 
Immunoreactivity of CNC-associated markers could be 
verified on protein level
  Most of the selected CNC-associated markers (Supple-
mentary Table S4) are not exclusively expressed in NC 
and CNC tissue, but also in other tissues and cell types, 
in particular in cardiac cells (21). To investigate, whether 
selected CNC-associated markers are also expressed in 
non-CNC-like cells such as cardiac, endothelial or neuro-
nal derivatives, IF analyses were performed (Fig. 2). 
  For a better visualization of cardiac cell derivatives, iso-
lated beating cardiac clusters (29) were stained. IF analy-
ses showed strong co-expressions of the sarcomere-specific 
protein α-Actinin2 with Snai2 at the early differentiation 
stage 5＋4＋1d (Fig. 2C) and other CNC-associated mark-
ers as Snai1 (Fig. 2B), Cx43 (Fig. 2D), Pitx2 (Fig. 2E), 
Mef2c (Fig. 2G), Hand1 (Fig. 2H), Hand2 (Fig. 2I) and 
Lbx1 (Fig. 2J) at differentiation stage 5＋7＋1d. At the 
same stage, a co-expression of the sarcomere-specific pro-
tein Troponin T with Pax3 was observed (Fig. 2A). 
  IF analysis of non-isolated cardiac cells at stage 5＋9d 
revealed a partial co-expression of α-Actinin2 with the 
endothelin A receptor (ET-AR) (Fig. 2F). To elucidate the 
expression pattern of CNC-associated markers also in 
non-cardiac cells, Snai1 (Fig. 2K), Lbx1 (Fig. 2L) and 
Pax3 (Fig. 2M) were co-stained either with endothelial 
(CD144/VE-Cadherin, Fig. 2K), neuronal (Tubb3, Fig. 
2L) or skeletal/cardiac muscle (α-Actinin2, Fig. 2M) 
cell-specific markers. A strong co-immunoreactivity was 
detected for CD144 and Snai1 in endothelial-like cells at 
the early differentiation stage 5＋4d (Fig. 2K), as well as 
for the pan-neuronal marker Tubb3 and Lbx1 (Fig. 2L) 
at the more advanced differentiation stage 5＋15d. At the 
same differentiation stage, a strong co-immunoreactivity 
in skeletal muscle cells was observed for the skeletal/car-
diac muscle cell specific marker α-Actinin2 and Pax3 
(Fig. 2M). 
4E9R immunoreactivity decreases in heart and ES cell 
specimens with advancing differentiation 
  In order to elucidate the expression pattern of the NC/ 
CNC-specific marker 4E9R in ES cell-derived progeny, ES 
cell specimens, as well as primary CNC cells at E10.5 were 
analyzed by Western blot (Fig. 3). The detected immu-
nogen of 4E9R had a molecular size of ∼15 kDa. In con-
trast to primary CNC cells (E10.5), undifferentiated ES 
cells displayed only a faint band. However, ES cell speci-
mens at stages 5d-5＋7d showed a very strong immunor-
eactivity for 4E9R. During progressive differentiation at 
the intermediate and more advanced stages (from 5＋9d 
to 5＋21d), 4E9R immunoreactivity decreased. The lowest 
4E9R expression was detected at stage 5＋25d (Fig. 3).
70  International Journal of Stem Cells 2020;13:65-79
Fig. 1. Comparative expression analyses of undifferentiated ES cells and ES cell-derived progeny using selected CNC-associated markers. 
(A∼E) Investigated genes were arranged according to their putative role in the CNC (adapted from (30)). Undifferentiated ES cells (0 days; 
d) are shown in black and embryoid body formation stages are indicated in dark grey (2d, 5d). Differentiation stages 5＋2d-5＋35d are 
shown in light grey. Column bar graphs are presenting the mean values of ten independent experiments with corresponding standard 
deviations.
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Fig. 2. Immunofluorescence analyses of cardiac and non-cardiac ES cell-derived progeny. (A∼E, G∼J) Representative immunofluorescence 
analyses of isolated beating cardiac clusters using CNC-associated (all in red) and the cardiomyocyte-specific markers α-Actinin2 and 
Troponin T (both in green) (A, B, D, E, G∼J: 5＋7＋1d; C: 5＋4＋1d). (F) Staining of non-isolated ES cell-derived cardiac progeny at 
stage 5＋9d using α-Actinin2 and ET-AR (endothelin-1). (K∼M) Immunofluorescence analyses of non-cardiac ES cell-derived progeny using 
CNC-associated markers (all in red) and endothelial cell- (CD144/VE-Cadherin), neuronal cell- (Tubb3) and skeletal muscle cell-specific 
(α-Actinin2) markers (K: 5＋4d; L, M: 5＋15d). White arrows indicate co-expression. Nuclei were counterstained with DAPI in blue. Bars: 
50 μm (D, L); 20 μm (B, C, F∼K, M); 10 μm (A, E). 
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Fig. 3. Western blot analyses of primary CNC cells and ES cell specimen using the 4E9R antibody. Comparative immunoblot analysis 
of CNC cells (1) as well as ES cell-derived specimens at various differentiation stages: 2) undifferentiated ES cells, 3) 5d EBs; 4) 5＋2d; 
5) 5＋4d; 6) 5＋7d; 7) 5＋9d; 8) 5＋11d; 9) 5＋14d; 10) 5＋18d; 11) 5＋21d; 12) was performed using 4E9R antibody. For protein integrity 
the reference protein Gapdh was used as loading control. E: embryonic day, undiff.: undifferentiated, d: day, EB: embryoid body.
The application of 4E9R enables the unambiguous 
identification of ES cell-derived CNC-like cells 
  To identify potential ES cell-derived CNC-like cells, IF 
analyses were performed using the NC/CNC cell-specific 
antibody, 4E9R (22, 23). To investigate the staining pat-
tern of 4E9R in non-NC/CNC-derivatives such as skeletal 
muscle cells, ES cell-derived cells were stained with 4E9R 
and the skeletal muscle cell marker α-Actinin2 (Fig. 4A). 
At the more advanced differentiation stage 5＋26d, the 
cells displayed only a positive immunoreactivity for α-Acti-
nin2, but not for 4E9R (Fig. 4A). Thereafter, ES cell-de-
rived smooth muscle and neuronal cells, which represent 
derivatives of the NC/CNC, were stained with 4E9R and 
cell lineage-specific markers such as α-Actin2 for smooth 
muscle cells as well as Nestin and Tubb3 for neuronal 
cells (Fig. 4B∼D). IF analyses revealed a positive staining 
for 4E9R either with α-Actin2 (Fig. 4B), Nestin (Fig. 4C) 
or Tubb3 (Fig. 4D) at intermediate differentiation stages 
(5＋5d-5＋9d). Subsequently, ES cell derivatives were 
stained with 4E9R and selected CNC-associated markers 
(Supplementary Table S4). Due to the modified staining 
protocol, using formalin/MeOH fixation, only Mef2c (Fig. 
4E), Cx43 (Fig. 4F), Hand2 (Fig. 4G and 4J), Pax3 (Fig. 
4H) and Lbx1 (Fig. 4I) showed a positive immunor-
eactivity, when stained together with the NC/CNC-specif-
ic marker 4E9R at various differentiation stages. In all 
previous staining analyses, an intermediate filament-like 
staining pattern was observed for 4E9R, but the co-appli-
cation of 4E9R with Cx43 revealed for the first time a stri-
ated/sarcomere-like pattern for 4E9R (Fig. 4F). 
ES cell-derived cardiomyocytes show a spatiotemporal 
restricted expression pattern of 4E9R 
  To examine the striated/sarcomere-like staining pattern 
of 4E9R, isolated beating cardiac clusters were co-stained 
with the 4E9R antibody and various sarcomere-specific 
antibodies against Titin, α-Actinin2 and Mlc2a (Supple-
mentary Fig. S2). A small subpopulation of early ES cell- 
derived cardiomyocytes showed a positive co-expression of 
Titin (Supplementary Fig. S2A and S2A’), α-Actinin2 
(Supplementary Fig. S2B and S2B’) and Mlc2a (Supple-
mentary Fig. S2C and S2C’) with 4E9R, respectively. 
Remarkably, in those cells a clear, striated, sarcomere-like 
pattern for 4E9R was detected, but no overlap with the 
assessed sarcomere proteins. At the more advanced differ-
entiation stage 5＋14d, the striated-like pattern of 4E9R 
changed into a dotted, diffuse, non-filamentous and non- 
striated staining pattern, while the Titin (Supplementary 
Fig. S2D and S2D’), α-Actinin2 (Supplementary Fig. S2E 
and S2E’) and Mlc2a (Supplementary Fig. S2F and S2F’) 
pattern did not change.
Most co-immunoprecipitated proteins represent 
isoforms of myosin, light polypeptide 6
  To elucidate the expression pattern of the NC/CNC- 
specific marker 4E9R, various heart specimens, including 
primary CNC cells at E10.5, were analyzed by Western 
blot (Fig. 5A). The detected immunogen of 4E9R had a 
molecular size of ~15 kDa. In primary CNC cells (E10.5), 
embryonic heart tissues (E10.5∼E17.5) and P8 heart tis-
sue, strong 4E9R immunosignals were observed. Whereas, 
at P15 and adult heart tissue, almost no 4E9R reactive 
protein was detectable (Fig. 5A).
  To identify the unknown epitope(s) recognized by the 
4E9R antibody, IP analyses with protein lysates isolated 
from whole-mount embryos, primary CNC cells, embry-
onic and adult heart tissue, and ES cell-derived specimen 
were performed (Fig. 5B). SDS-PAGE and Coomassie 
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Fig. 4. Immunofluorescence analyses of multilineage ES cell-derivatives using the NC/CNC-specific marker 4E9R. (A) Immunocytochemistry 
of ES cell-derived non-CNC-related skeletal muscle cells applying 4E9R (green) and the skeletal muscle cell-specific antibody α-Actinin2 
(red). (B∼D): Representative immunofluorescence staining of ES cell-derived CNC progeny using 4E9R (in green) and lineage-specific mark-
ers as α-Actin2 for smooth muscle cells (B) as well as Nestin (C) and Tubb3 (D) for neuronal cells (all in red). (E∼J) Immunofluorescence 
analysis of ES cell-derived progeny using 4E9R (in green) and CNC-associated markers such as Mef2c (E), Cx43 (F), Hand2 (G, J), Pax3 
(H) and Lbx1 (I) (all in red). White arrows indicate co-expression. Nuclei were counterstained using DAPI (blue). Bars: 50 μm (A∼E, 
G∼J); 10 μm (F).
Blue staining identified multiple co-precipitated proteins. 
A consistent triplet banding pattern ranging from 15 to 
17 kDa was detectable in almost every IP sample, except 
for the adult heart tissue (Fig. 5B’). In total, 17 bands 
were selected for nLC-ESI-MSMS analysis. IP results were 
analyzed using the Mascot server database tool (matrix-
science.com) and classified according to the identified 
amino acid sequences (matched peptides), molecular 
weight and the Mascot ion score. For reliable protein iden-
tification, the Mascot ion score should be around 100 
(www.matrixscience.com). The molecular weight, scores 
(＞100), sequence coverage and matched peptides of 
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Fig. 5. Western blot and IP analyses of various heart specimen. (A) Comparative Western blot analysis of NC cells, embryonic, postnatal 
and adult heart tissue immunostained against 4E9R and Gapdh: 1) CNC cells E10.5; 2∼9) embryonic heart tissue (E10.5∼E17.5); 10) 
postnatal heart P8; 11) postnatal heart P15; 12) adult heart. For protein integrity the reference protein Gapdh was used as loading control. 
E: embryonic day, P: postnatal day, d: day. (B) Coomassie Blue stained SDS-PAGE resulting from immunoprecipitation with 4E9R antibody. 
The IP was performed with protein lysates of several tissue and ES cell-derived specimen at various differentiation stages. Numbers 1∼17 
indicate the gel bands analyzed by nLC-ESI-MSMS. All investigated samples showed a triplet band pattern between 15 and 17 kDa except 
the adult heart tissue, where the lowest band is missing (indicated by the red arrow). (B’) Magnified section showing a selection of analyzed 
samples including adult heart tissue. Identified proteins and corresponding accession numbers are listed in Supplementary Tables S5 and S6.
co-immunoprecipitated proteins are presented in Supple-
mentary Tables S5 and S6.
  Co-immunoprecipitated proteins in lanes 1∼4 (Fig. 5B, 
Supplementary Table S5) represent several isoforms of 
myosin 10, vimentin, alpha and gamma actin with molec-
ular weights between 39 and 232 kDa. Based on immuno-
blot results, the as yet to be identified immunogenic pro-
tein had a molecular weight of ~15 kDa. Therefore, pro-
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Fig. 6. Comparative expression analyses elucidating the respective immunoreactivity of Mlc-3 and 4E9R. (A) Western blot analysis of primary 
murine heart tissues immunostained with Mlc-3 (13 kDa, predicted: 17 kDa) and 4E9R (15 kDa). 1∼8 embryonic heart tissues (1: E10.5; 
2: E11.5; 3: E12.5; 4: E13.5; 5: E14.5; 6: E15.5, 7: E16.5; 8: E17.5); 9) postnatal heart tissue P8; 10) postnatal heart tissue P15; 11) adult 
heart tissue. (B) Immunoblot of undifferentiated (undiff.) and differentiated ES cell-derived specimens. 1) undiff. ES cells; 2) 5d EBs; 3) 
5＋2d; 4) 5＋4d; 5) 5＋7d; 6) 5＋9d; 7) 5＋14d; 8) 5＋25d. As a loading control, the reference protein Gapdh (40 kDa) was used. (C∼E) 
Immunofluorescence analyses comparing the staining patterns of Mlc-3 (red) and 4E9R (green) in non-cardiac (C; 5＋5d), neuronal (D; 
5＋7d) and cardiac (E, E’; 5＋7d) ES cell-derived progeny. The white box indicates the magnified area (E), whereas the white arrow shows 
the co-labeling of Mlc-3 and 4E9R (E’). Nuclei were counterstained using DAPI (blue). Bars: 50 μm (C), 20 μm (D, E).
teins with different molecular weights were excluded from 
further analyses, but may represent potential binding or 
interaction partners of the 4E9R reactive protein. Co-pre-
cipitated proteins in lanes 5∼8 (Fig. 5B, Supplementary 
Table S5) were ribosomal proteins, cytochromes and histo-
nes.
  Remarkably, several isoforms of ‘myosin light polypep-
tide 6 (Mlc-3)’ were identified in bands 9 to 17, with vary-
ing scores and sequence coverage (Fig. 5B, Supplementary 
Table S6). The lowest scores (＜50) were observed in lanes 
9 (score 43) and 15 (both E13.5, score 42), 13 (CNC cells, 
score 35) and 10 (adult heart, score 46). Intermediate 
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scores (＞50, ＜100) were reported for lanes 11 (score 59), 
16 (both 5＋7d, score 62) and 14 (E10.5 heart, score 92). 
Proteins with the highest scores and coverage were ob-
served in lanes 12 (score 151) and 17 (both 5＋18d, score 
151) (Fig. 5B, Supplementary Table S6). Interestingly, no 
protein band of this molecular weight was detected in 
adult heart tissue.
Mlc-3 and 4E9R antibody displayed a similar but not 
identical expression pattern
  To investigate, whether Mlc-3 contains the unknown 
epitope recognized by 4E9R, Western blot (Fig. 6A and 
6B) as well as IF analyses of early, unspecified non-cardiac 
(5＋5d, Fig. 6C), neuronal (5＋7d, Fig. 6D) and cardiac 
(5＋7d, Fig. 6E) ES cell derivatives were performed. For 
Western blot analysis, several embryonic and postnatal 
heart (Fig. 6A) as well as ES cell-derived specimens (Fig. 
6B) were investigated by the co-application of 4E9R and 
Mlc3- antibodies. The immunoblot analysis revealed a 
similar expression pattern for 4E9R and Mlc-3 in embry-
onic and postnatal primary heart tissues except for devel-
opmental stages E15.5 (Fig. 6A, (6)), E16.5 (Fig. 6A, (7)) 
and E17.5 (Fig. 6A, (8)) where no Mlc-3 expression was 
detectable. However, both antibodies did not show a pos-
itive staining in the postnatal stage P15 and in the adult 
heart tissue. ES cell-derived specimens showed as well a 
similar expression pattern for 4E9R and Mlc-3, except in 
undifferentiated ES cells (Fig. 6B, (1)) and the early dif-
ferentiation stages 5d EB (Fig. 6B, (2)) and 5＋2d (Fig. 
6B, (3)). Despite similar expression pattern of 4E9R and 
Mlc-3 in all assessed specimens, both recognized epitopes 
displayed different molecular weights (Fig. 6A and 6B). 
Comparative IF analyses showed as well no overlapping 
staining pattern for Mlc-3 and 4E9R (Fig. 6C∼E). How-
ever, a co-expression within in the same cell but no over-
lapping staining pattern of 4E9R and Mlc-3 was observed 
in cardiac progeny (Fig. 6E and 6E’). Remarkably, the an-
ti-Mlc-3 antibody displayed a filamentous staining pattern 
in non-cardiac cells (Fig. 6C and 6D) and a striated stain-
ing pattern in cardiac cells (Fig. 6E and 6E’), similar to 
the 4E9R antibody. 
Discussion
  Pluripotent ES cells represent an unique cell resource 
for numerous applications, as they are characterized by a 
nearly unlimited self-renewal and differentiation capacity 
(3). Besides the capacity to develop into derivatives of the 
three primary germ layers, mouse and human pluripotent 
stem cells have also been shown to generate cell deriva-
tives of the ‘fourth’ germ layer, the NC (31).
  In an earlier study, we had differentiated murine ES 
cells according to a mesodermal-lineage promoting proto-
col and performed comparative expression analyses of un-
differentiated and differentiated ES cell specimens at 
stage 5＋9d (6). Affymetrix gene chip-based expression 
profiling has provided first evidence that ES cells can be 
differentiated into NC/CNC-like cells as an upregulation 
of NC and CNC markers in differentiated specimens was 
observed (Rolletschek, et al., unpublished) (6). For ver-
ification and further molecular characterization, we differ-
entiated murine ES cells of line R1 according to the meso-
dermal-lineage promoting protocol as described earlier (6). 
Initial, morphological assessment revealed ES cell progeny 
of the mesodermal lineage, but also ectodermal deriva-
tives. For the establishment of appropriate CNC cell mod-
els, a heterogenous mixture of diverse cell types is a cru-
cial prerequisite for mimicking the in vivo situation at its 
best. Thus, the existence of different cell types in our ES 
cell cultures hold a great advantage for prospective CNC 
cell models.
  Subsequent expression analyses in our current study on 
mRNA and protein level verified the Affymetrix gene chip 
data as ES cell-derived progeny showed a strong ex-
pression of selected NC/CNC-associated markers. However, 
selected CNC-associated markers are also expressed by 
other cell types, in particular cardiac cells (21). In order 
to confirm the identity of potential ES cell-derived NC/ 
CNC-like cells, a NC-specific antibody (4E9R) was ap-
plied (22). Several studies had previously verified this an-
tibody as a suitable NC cell-specific marker (22, 32-34), 
and it was also demonstrated that it identifies CNC cells 
(23). Furthermore, it was shown that the immunoreacti-
vity of 4E9R is restricted to early developmental stages, 
as with progressing development its reactivity is decreas-
ing (22). 
  To confirm its specificity also for murine ES cells, we 
co-stained ES cell-derived smooth muscle and neuronal 
cells, which represent derivatives of the NC/CNC (8), ap-
plying the 4E9R antibody combined with lineage-specific 
markers such as α-Actin2 (smooth muscle cells), Nestin 
and Tubb3 (neuronal cells). In line with earlier studies 
(22), with advancing development, the number of 4E9R- 
positive cells seemed to decrease and only a partial co-ex-
pression of 4E9R with the lineage-specific markers was 
detectable. In addition, we implemented ES cell-derived 
skeletal muscle cells, which are no NC/CNC-derivatives 
and performed a co-staining using 4E9R antibody and the 
lineage-specific marker α-Actinin2. Remarkably, ES cell- 
derived skeletal muscle cells showed no co-expression with 
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4E9R. 
  Finally, we could confirm the terminable expression 
pattern of 4E9R in our study by Western blot analysis of 
ES cell and mouse heart specimens at various devel-
opmental stages. 
  In conclusion, the 4E9R antibody represents a perfect 
tool for unambiguous identification of ES cell-derived 
NC/CNC-like cells. Immunofluorescence analyses using 
4E9R and CNC-associated markers revealed a partial 
overlap. Due to the modified staining protocol for 4E9R 
(formaldehyde/MeOH fixation at −20℃), a co-staining 
for not all selected CNC-associated markers worked out 
although they showed an immunoreactivity in the non- 
modified procedure using PFA (at RT) for fixation. 
  However, our results indicate that murine ES cells can 
be differentiated into NC/CNC-like cells. To strengthen 
these results, further CNC-associated markers need to be 
tested in combination with 4E9R.
  In addition, we monitored that the staining pattern gen-
erated by 4E9R changed from filamentous to striated/sar-
comere-like as seen in Cx43-positive cells. As Cx43 is also 
a typical marker for cardiomyocytes, 4E9R was further-
more applied together with the sarcomere-specific markers 
(Titin, α-Actinin2, Mlc2a) on isolated cardiac clusters. 
Immunofluorescence analysis revealed a striated, but 
non-overlapping staining pattern of 4E9R in early cardio-
myocytes. In more advanced differentiation stages, the 
striated pattern of 4E9R changed again, into a dotted and 
diffuse staining. 
  To identify the still unknown epitope/s recognized by 
4E9R, IP analyses were performed. The most abundant 
co-precipitated proteins belonged to the Mlc-3, myosin 
light chain, smooth muscle and non-muscle protein 
family. Several isoforms of Mlc-3 of varying molecular 
weights, scores and sequence coverages were identified. To 
follow up these findings, Western blot analyses were per-
formed which revealed similar expression patterns of 
4E9R and Mlc-3 but different molecular weights. Subse-
quent IF analyses using both antibodies showed no co-ex-
pression in non-cardiac cells and a co-expression but no 
overlapping staining pattern in cardiac progeny. 
  This data suggests, that the 4E9R immunogen could 
represent a specific spatiotemporally expressed as yet to 
be identified isoform of Mlc-3. Its immunoreactivity in 
cardiomyocytes might point to a differentiation of CNC 
cells into early cardiomyocytes as already described in ze-
brafish (35-37) and mice (31). First evidence was gen-
erated in mice as it was shown that CNC cells are able 
to migrate into the developing heart, where they persist 
as dormant tissue-specific progenitors until adulthood. 
Upon appropriate stimulation they can give rise to NC 
cell derivatives, including peripheral neurons, glia, smooth 
muscle cells and cardiomyocytes (38, 39). These findings 
were lately supported by a genetic fate-mapping approach 
which showed that cKit delineates CNC progenitor cells, 
which exhibit the capacity to differentiate into cardiomy-
ocytes and other CNC derivatives (40). 
  Our data suggest that murine ES cells have the capacity 
to differentiate into NC/CNC-like cells in vitro, as demon-
strated by the immunoreactivity of CNC-associated mark-
ers and the NC/CNC cell-specific marker, 4E9R. We also 
investigated the still unknown immunogen of 4E9R and 
could show that it might represent a spatiotemporally ex-
pressed isoform of Mlc-3. Whether ES cell models can 
properly simulate the differentiation of CNC cells into 
cardiomyocytes and whether the 4E9R reactive protein 
contributes to CNC cells in early cardiomyogenic develop-
ment remains to be elucidated. 
  Finally, our data clearly illustrates that ES cells can be 
differentiated into CNC-like cells and thereby providing 
a crucial basis for the establishment of novel CNC cell 
models. 
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